Clinical Trial Update: Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis

View source ↗

Summary

Observational study update of denosumab (Prolia) in postmenopausal osteoporosis; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Prolia (denosumab)

Snippet

Sponsor: Amgen | Conditions: Postmenopausal Osteoporosis | Status: COMPLETED | Results posted: 2016-09-20